Clinical practice guideline on diagnosis and treatment of hyponatraemia. (Q34406779)

2 August 2017

title

Clinical practice guideline on diagnosis and treatment of hyponatraemia. (English)

1 reference

2 August 2017

Goce Spasovski

1 reference

2 August 2017

Raymond Vanholder

1 reference

2 August 2017

Wim Van Biesen

1 reference

2 August 2017

Djillali Annane

1 reference

2 August 2017

Evi Nagler

1 reference

2 August 2017

Michael Joannidis

1 reference

2 August 2017

Bruno Allolio

1 reference

2 August 2017

Steve Ball

1 reference

2 August 2017

Daniel Bichet

1 reference

2 August 2017

Guy Decaux

1 reference

2 August 2017

Wiebke Fenske

1 reference

2 August 2017

Ewout J Hoorn

1 reference

2 August 2017

Carole Ichai

1 reference

2 August 2017

Alain Soupart

1 reference

2 August 2017

Robert Zietse

1 reference

2 August 2017

Maria Haller

1 reference

2 August 2017

Sabine van der Veer

1 reference

2 August 2017

Hyponatraemia Guideline Development Group

1 reference

2 August 2017

language of work or name

English

0 references

publication date

25 February 2014

1 reference

Nephrology Dialysis Transplantation

2 August 2017

published in

1 reference

2 August 2017

volume

29 Suppl 2

1 reference

2 August 2017

page(s)

i1-i39

1 reference

AGREE II: advancing guideline development, reporting and evaluation in health care

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Asking the right question and finding the right answers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Epidemiology of hyponatremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Mild hyponatremia as a risk factor for fractures: The rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Impact of hospital-associated hyponatremia on selected outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia and mortality: moving beyond associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The molecular and cellular identity of peripheral osmoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

An N-terminal variant of Trpv1 channel is required for osmosensory transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The Interaction of Blood Osmolality and Blood Volume in Regulating Plasma Vasopressin in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia: evaluating the correction factor for hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia, hyposmolality, and hypotonicity: tables and fables

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Cisplatin-induced renal salt wasting syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Nephrogenic syndrome of inappropriate antidiuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Clinical practice. The syndrome of inappropriate antidiuresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Whole-body volume regulation and escape from antidiuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Beyond semantics: defining hyponatremia in secondary adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Disorders of sodium balance: hypothyroidism and hyponatraemia: an old wives' tale?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

"Beer potomania" in non-beer drinkers: effect of low dietary solute intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Peritoneal dialysis: new developments and new problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia and mortality among patients on the liver-transplant waiting list

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Mortality after hospitalization with mild, moderate, and severe hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Lesson of the week: Acute hyponatraemia in children admitted to hospital: retrospective analysis of factors contributing to its development and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Incidence and prognosis of dysnatremias present on ICU admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Postoperative hyponatremic encephalopathy in menstruant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatraemia and death or permanent brain damage in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Adaptive responses to sustained volume expansion in hyponatraemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Neurological and neuropathological sequelae of correction of chronic hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Biochemical and etiological characteristics of acute hyponatremia in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The rational clinical examination. Is this patient hypovolemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Body fluid dynamics: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Posttransurethral prostatic resection hyponatremic syndrome: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Milky plasma, diabetes, and severe hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Copeptin in the differential diagnosis of hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

21 January 2018

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Misinterpretation of serum cortisol in a patient with hyponatraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Severe hyponatremia with high urine sodium and osmolality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Rapid correction of severe hyponatremia with intravenous hypertonic saline solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hypertonic saline for hyponatremia: risk of inadvertent overcorrection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Management of severe hyponatremia: rapid or slow correction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Osmotic demyelination syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A trident in the brain, central pontine myelinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

"Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Central pontine myelinolysis following 'optimal' rate of correction of hyponatraemia with a good clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Central pontine myelinolysis in a previously healthy 4-year-old child with acute rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Ocular motor and imaging abnormalities of midbrain dysfunction in osmotic demyelination syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Best cases from the AFIP: osmotic demyelination syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Myelinolysis after correction of hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Extra pontine myelinolysis in a tetraplegic patient: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Case seminar: a young female with acute hyponatremia and a sellar mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Central pontine and extrapontine myelinolysis despite careful correction of hyponatremia: clinical and neuropathological findings of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Osmotic Myelinolysis with Malignant Cerebellar Edema Occurring after DDAVP-Induced Hyponatremia in a Child

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Severe hyponatraemia and central pontine myelinolysis: be careful with other factors!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Extrapontine myelinolysis after surgical removal of a pituitary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Neuropsychological findings of extrapontine myelinolysis without central pontine myelinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Central pontine myelinolysis: sequele of hyponatremia during transcervical resection of endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Osmotic demyelination syndrome following rapid correction of hyponatraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Klüver Bucy syndrome, unusual consequence of excessively rapid correction of severe hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Pontine and extrapontine osmotic myelinolysis after the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

(99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The treatment of hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Treatment of euvolemic hyponatremia in the intensive care unit by urea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Lack of efficacy of phenytoin in the syndrome of inappropriate anti-diuretic hormone secretion of neurological origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Renal Failure Associated with Demeclocycline in Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Superiority of Demeclocycline over Lithium in the Treatment of Chronic Syndrome of Inappropriate Secretion of Antidiuretic Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Serious hyponatremia in patients with cancer: management with demeclocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Treatment of psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) using lithium and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Demeclocycline-induced phosphate diabetes in patients with inappropriate secretion of antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

GRADE guidelines: 3. Rating the quality of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Going from evidence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Evaluation and management of hypo-osmolality in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate--a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A case of Langerhans'-cell histiocytosis with membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

A review of drug-induced hyponatremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU040

21 January 2018

Identifiers

DOI

10.1093/NDT/GFU040

1 reference

2 August 2017

1 reference